Table 2.
ID | Gender | Age | Morphology | Gene | Chr | Location | SNP IDS | REF | VAR | Variant Type |
Protein Change |
Variant Impact |
Pathogenecity Prediction a | HGMD/ ClinVar |
MAF in Control Datasets | Pathway/Process | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
METASVM | METALR | CADD | gnomAD Exomes EAS b | gnomAD Genomes EAS c | |||||||||||||||
1804 | M | 65 | Conventional | ATP8B2 | 1 | 154317567 | A | C | missense | Lys836Gln | moderate | D | D | 26.2 | 1.74 × 10−4 | 0 | Mesoderm commitment | ||
1686 | M | 64 | Conventional | LRP2 | 2 | 170033035 | C | T | missense | Gly3486Glu | moderate | D | D | 33 | 0 | 0 | Sonic Hedgehog | ||
1372 | NA | NA | NA | LRP2 | 2 | 170062924 | rs577943281 | T | A | missense | Thr2436Ser | moderate | D | D | 22.7 | 2.90 × 10−4 | 6.17 × 10−4 | Sonic Hedgehog | |
1964 | M | 24 | Chondroid | LRP2 | 2 | 170055366 | rs755215116 | A | C | missense | Ile2836Met | moderate | D | D | 24.2 | 3.66 × 10−3 | 6.17 × 10−4 | Sonic Hedgehog | |
1442 | NA | NA | NA | PDK1 | 2 | 173460575 | rs745678398 | A | G | structural interaction | High | 0 | 0 | PI3K/AKT/mTOR | |||||
1886 | F | 62 | Conventional | TCF7L1 | 2 | 85536476 | C | T | missense | Thr553Ile | moderate | D | D | 23 | 5.82 × 10−5 | 0 | Mesoderm commitment | ||
1790 | M | 65 | Conventional | TCF7L1 | 2 | 85531113 | rs373770977 | G | A | missense | Val252Ile | moderate | D | D | 23.4 | 1.25 × 10−4 | 0 | Mesoderm commitment | |
1779 | M | 47 | Conventional | TCF7L1 | 2 | 85536536 | rs555810312 | C | T | missense | Pro573Leu | moderate | D | D | 23.2 | 4.19 × 10−4 | 0 | Mesoderm commitment | |
2011 | F | 7 | Conventional | TBXT | 6 | 166581010 | rs563349798 | C | G | missense | Val24Leu | moderate | D | D | 29.7 | 0 | 0 | T super-enhancer | |
1686 | M | 64 | Conventional | EXT1 | 8 | 118819501 | rs753261171 | G | A | missense | Thr613Met | moderate | D | D | 33 | 0 | 0 | Mesoderm commitment | |
776 | M | 54 | Conventional | SUFU | 10 | 104309738 | C | T | structural interaction | High | 5.80 × 10−5 | 0 | Sonic Hedgehog | ||||||
1921 | M | 57 | Conventional | EXT2 | 11 | 44193231 | rs767085143 | A | G | missense | Asn448Ser | moderate | D | D | 24.3 | 2.90 × 10−4 | 0 | Mesoderm commitment | |
1372 | NA | NA | NA | COL2A1 | 12 | 48369322 | rs995646562 | C | T | missense | Ala1222Thr | moderate | D | D | 24.1 | 0 | 0 | Notochord development | |
1909 | M | 26 | Conventional | COL2A1 | 12 | 48372528 | G | T | missense | Pro916His | moderate | D | D | 25 | 0 | 0 | Notochord development | ||
1936 | F | 71 | Conventional | TSC2 | 16 | 2134572 | rs45517338 | C | G | missense | Pro1450Arg | moderate | D | D | 25.8 | 2.35 × 10−4 | 0 | PI3K/AKT/mTOR | |
1417 | M | 59 | Conventional | TSC2 | 16 | 2134572 | rs45517338 | C | G | missense | Pro1450Arg | moderate | D | D | 25.8 | 2.35 × 10−4 | 0 | PI3K/AKT/mTOR | |
1979 | M | 59 | Chondroid | TSC2 | 16 | 2121610 | rs45509392 | G | A | missense | Asp647Asn | moderate | D | D | 32 | DM | 5.80 × 10−4 | 0 | PI3K/AKT/mTOR |
1570 | M | 24 | Chondroid | TSC2 | 16 | 2121610 | rs45509392 | G | A | missense | Asp647Asn | moderate | D | D | 32 | DM | 5.80 × 10−4 | 0 | PI3K/AKT/mTOR |
462 | F | 62 | Conventional | TSC2 | 16 | 2121610 | rs45509392 | G | A | missense | Asp647Asn | moderate | D | D | 32 | DM | 5.80 × 10−4 | 0 | PI3K/AKT/mTOR |
1084 | NA | NA | NA | ACACA | 17 | 35549102 | rs772483773 | C | T | missense | Val1449Met | moderate | D | D | 25.2 | 6.96 × 10−4 | 6.17 × 10−4 | Mesoderm commitment |
Chr, chromosome; REF, reference allele; VAR, variant allele; Freq, frequency; MAF, minor allele frequency; T, tolerant; D, deleterious; P, pathogenic; DM, disease-causing mutation. a Pathogenicity prediction for missense variants based on in silico algorithms, METALR and METASVM, which are ensemble prediction scores that incorporate results from nine algorithms and allele frequency. CADD was also applied. b,c Genome Aggregation Database (gnomAD) exomes and genomes, respectively, in East Asian population. Structural interaction: variants that impact the internal interactions of the resulting polypeptide structure.